DOI:
10.1055/s-00000030
Der Klinikarzt
LinksClose Window
References
Moore KN, Geller MA, Miller DS. et al. QUADRA: A phase 2, open-label, single-arm study to evaluate niraparib in
patients (pts) with relapsed ovarian cancer (ROC) who have received ≥3 prior
chemotherapy regimens
J Clin Oncol 2018;
36 (suppl; abstr 5514) 2018
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.